API
EW icon

Advisor Partners II’s Edwards Lifesciences EW Stock Holding History

Advisor Partners II’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.71M Sell
24,672
-2,660
-10% -$214K 0.07% 313
2023
Q2 		$2.58M Buy
27,332
+1,772
+7% +$154K 0.12% 165
2023
Q1 		$2.11M Buy
25,560
+3,276
+15% +$258K 0.12% 179
2022
Q4 		$1.66M Buy
22,284
+3,353
+18% +$258K 0.1% 219
2022
Q3 		$1.56M Buy
+18,931
New +$1.82M 0.12% 182

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Advisor Partners II's EW Position: Q3 2023 in Review

Advisor Partners II reduced its Edwards Lifesciences (EW) stake by 9.7% in Q3 2023, selling an estimated $214K and leaving 24,672 shares worth $1.71M. The position accounts for 0.07% of the portfolio, ranked #313.

Advisor Partners II first reported a position in EW in Q3 2022 and has held it in 5 quarters since. The position peaked at $2.58M in Q2 2023. 1,219 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Advisor Partners II held 24,672 shares of Edwards Lifesciences worth $1.71M as of Q3 2023.
  • Advisor Partners II sold 2,660 Edwards Lifesciences shares in Q3 2023, an estimated $214K.
  • Edwards Lifesciences made up 0.07% of Advisor Partners II's portfolio in Q3 2023, its #313 holding.
  • Advisor Partners II first reported a position in Edwards Lifesciences in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Edwards Lifesciences position peaked at $2.58M in Q2 2023.
  • 1,219 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.